What question did this study set out to answer?

To evaluate the clinical diagnostic impact and subsequent treatment changes of integrating a DNA methylation-based classifier for challenging central nervous system tumors.

December 1, 2019Clinical EpigeneticsOpen Access

The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care

View Full Paper

Ask AI

Bookmark

Authors

SKShirin KarimiUniversity Health Network JZJeffrey ZuccatoUniversity of Oklahoma Health Sciences Center YMYasin MamatjanThompson Rivers University

Discussion

Member takes

Implication

Cohort study reveals DNA methylation profiling alters diagnosis in 84% of challenging brain tumors, indicating substantial improvements in targeted neuro-oncology treatment decisions.

Key Points

To evaluate the clinical diagnostic impact and subsequent treatment changes of integrating a DNA methylation-based classifier for challenging central nervous system tumors.
Prospective case review of 55 central nervous system tumors with uncertain diagnoses identified during multidisciplinary tumor board discussions over 3 years.
Methylation profiling, calibrated classification scores, and copy number variant plots were generated and integrated with histopathological assessments.
Retrospective chart reviews determined final neuropathological diagnoses and evaluated direct alterations to patient treatment and management plans.
Methylation profiling led to clinically relevant diagnostic alterations in 84% (46/55) of challenging cases, including histopathological changes in two-thirds and molecular subtyping revisions in one-third.
World Health Organization tumor grading changed in 27% of cases, with two-thirds receiving a higher grade.
Clinical treatment plans were directly modified in 15% of all cases to avoid unnecessary or insufficient interventions.

Cite This Study

Karimi et al. (2019) studied this question.

synapsesocial.com/papers/6a7adfb48d250a4360f43d03 https://doi.org/10.1186/s13148-019-0766-2

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals DNA methylation profiling alters diagnosis in 84% of challenging brain tumors, indicating substantial improvements in targeted neuro-oncology treatment decisions.

The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care

Discussion

Member takes

Implication

Key Points

Cite This Study

The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider